Atlas Trials

Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis

Clinical trial NCT02894684 · COMPLETED

Trial details

NCT number
NCT02894684
Sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cystic FibrosisInfectionPseudomonas
Start date
2017-01-01
Primary completion
2019-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.